Malpractice in Dermatopathology—Principles, Risk Mitigation, and Opportunities for Improved Care for the Histologic Diagnosis of Melanoma and Pigmented Lesions

Troxel, 2003, Pitfalls in the diagnosis of malignant melanoma, Am J Surg Pathol, 27, 1278, 10.1097/00000478-200309000-00012 Troxel, 2005, An insurer's perspective on error and loss in pathology, Arch Pathol Lab Med, 129, 1234, 10.5858/2005-129-1234-AIPOEA Troxel, 2006, Medicolegal aspects of error in pathology, Arch Pathol Lab Med, 130, 617, 10.5858/2006-130-617-MAOEIP Read, 2005, Dermatology's malpractice experience: clinical settings for risk management, J Am Acad Dermatol, 53, 134, 10.1016/j.jaad.2005.02.019 Lydiatt, 2004, Medical malpractice and cancer of the skin, Am J Surg, 187, 688, 10.1016/j.amjsurg.2003.10.018 Glusac, 2003, Under the microscope: doctors, lawyers, and melanocytic neoplasms, J Cutan Pathol, 30, 287, 10.1034/j.1600-0560.2003.00075.x Albert, 1990, Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society, J Am Acad Dermatol, 23, 308, 10.1016/0190-9622(90)70214-3 Bevona, 2002, Melanoma incidence trends, Dermatol Clin, 20, 589, 10.1016/S0733-8635(02)00037-2 Erie Railroad v. Tompkins, 304 U.S. 64. 1938. Fox, 1996, “Curbside” consultation and informal communication in medical practice: a medicolegal perspective, Clin Infect Dis, 23, 616, 10.1093/clinids/23.3.616 Kelley v. Middle Tennessee Emergency Physicians, P.C., 133 S.W.3d 587 (Tenn. 2004). Scafide v. Bazzone, NO. 2004-CA-01658-COA (Miss.Ct. App. 2004). Epstein, 2001, Pathologists and the judicial process: how to avoid it, Am J Surg Pathol, 25, 527, 10.1097/00000478-200104000-00014 Troxel, 1994, Problem areas in pathology practice uncovered by a review of malpractice claims, Am J Surg Pathol, 18, 821, 10.1097/00000478-199408000-00009 Tomaszewski, 1999, Mandatory second opinion of pathologic slides: is it necessary?, Cancer, 86, 2198, 10.1002/(SICI)1097-0142(19991201)86:11<2198::AID-CNCR4>3.0.CO;2-G Dahl, 2006, Quality, assurance, diagnosis, treatment, and patient care, Pathology review—patient safety and quality healthcare Martello, 1999, Basic medical legal principles, Clin Plast Surg, 6, 9, 10.1016/S0094-1298(20)32312-9 Furrow, 1997 Vergara v Doan, 593 N.E.2d 185 (Ind. 1992). Kinney, 1989 Trotter, 2007, Interpretation of skin biopsies by general pathologists: diagnostic discrepancy rate measured by blinded review, Arch Pathol Lab Med, 127, 1489, 10.5858/2003-127-1489-IOSBBG Goldberg, 2006, Legal issues in laser operation, Clin Dermatol, 24, 56, 10.1016/j.clindermatol.2005.10.021 Gittler, 1996, Medicolegal case reviews, Clin Infect Dis, 23, 1152, 10.1093/clinids/23.5.1152 Melville v. Southward, 791 P.2d 383 (Colo. 1990). Marshall, 1995, Credibility: the key to the successful physician witness, Surv Ophthalmol, 40, 69, 10.1016/S0039-6257(95)80049-2 Palsgraf v Long Island Railway Co., 248 N.Y. 339 (N.Y. 1928). Callahan v. Cardinal Glennon Hosp., 863 S.W.2d 852 (Mo. 1993). St. George v. Pariser, 484 S.E.2d 888 (Va. 1997). American Academy of Pediatrics, 2000, Committee on Medical Liability. Professional liability coverage for residents and fellows, Pediatrics, 106, 605, 10.1542/peds.106.3.605 Pace, 2004 Ellington, 1997, The defense perspective, Med Malpractice, 94, 323 Moran, 1995, So you've been sued: tips for enduring and avoiding the malpractice roller coaster ride, Tex Med, 9, 24 Summerton, 2006, Effects of the medical liability system in Australia, the UK, and the USA, Lancet, 368, 240, 10.1016/S0140-6736(06)69045-4 Colorado Governmental Immunity Act. Colorado Revised Statutes, Section 24-10-101, 2006. National Institutes of Health. Consensus statement. Diagnosis and treatment of early melanoma. NIH Consensus Development Conference. Bethesda, MD, January 27–29, 1992. Balch, 2004, An evidence-based staging system for cutaneous melanoma, CA Cancer J Clin, 54, 131, 10.3322/canjclin.54.3.131 Balch, 2001, Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system, J Clin Oncol, 19, 3622, 10.1200/JCO.2001.19.16.3622 Hancox, 2005, Interpretation of dermatopathology specimens is within the standard of care of dermatology practice, Dermatol Surg, 31, 306, 10.1111/j.1524-4725.2005.31079 Kirsner, 2001, Interpretation of cutaneous biopsy specimens: choice of pathologist by primary care practitioners, South Med J, 94, 461, 10.1097/00007611-200105000-00001 American Board of Medical Specialites. Recognized physician specialty and subspecialty certificates. Available at: http://www.abms.org/Who_We_Help/Physicians/specialties.aspx. Accessed August 19, 2007. Grant-Kels, 2005, The whys and wherefores of who reads dermatopathology slides, J Am Acad Dermatol, 53, 703, 10.1016/j.jaad.2005.07.043 Ackerman, 2005, Dermatologist not equal to dermatopathologist: no place in a profession for pretenders, J Am Acad Dermatol, 53, 698, 10.1016/j.jaad.2005.06.025 Leboit, 1999, Fire your dermatopathologist!, Arch Dermatol, 135, 137, 10.1001/archderm.135.2.137 Barnhill, 1999, Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome, Hum Pathol, 30, 513, 10.1016/S0046-8177(99)90193-4 Crowson, 2006, Medicolegal aspects of neoplastic dermatology, Mod Pathol, 19, S148, 10.1038/modpathol.3800518 Brennan, 1991, Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I, N Engl J Med, 324, 370, 10.1056/NEJM199102073240604 Localio, 1991, Relation between malpractice claims and adverse events due to negligence. Results of the Harvard Medical Practice Study III, N Engl J Med, 325, 245, 10.1056/NEJM199107253250405 Studdert, 2006, Claims, errors, and compensation payments in medical malpractice litigation, N Engl J Med, 354, 2024, 10.1056/NEJMsa054479 Schmoeckel, 1985, Nevoid malignant melanoma, Arch Dermatol Res, 277, 362, 10.1007/BF00509234 Magro, 2006, Unusual variants of malignant melanoma, Mod Pathol, 19, S41, 10.1038/modpathol.3800516 McNutt, 1995, Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity, J Cutan Pathol, 22, 502, 10.1111/j.1600-0560.1995.tb01146.x Fernandez, 2005, The vanishing biopsy: the trend toward smaller specimens, Cutis, 76, 335 Clark, 1969, Lentigo maligna and lentigo-maligna melanoma, Am J Pathol, 55, 39 Pardasani, 2000, Fusiform incisional biopsy for pigmented skin lesions, Dermatol Surg, 26, 622, 10.1046/j.1524-4725.2000.00037.x Dalton, 2005, Contiguous lesions in lentigo maligna, J Am Acad Dermatol, 52, 859, 10.1016/j.jaad.2004.11.063 Rigel DS. Melanoma symposium. Presented at the Program of the 60th Annual Meeting. American Academy of Dermatology. New Orleans, LA, February 22–27th, 2002. Pariser, 1999, The relationship between biopsy technique and uncertainty in the histopathologic diagnosis of melanoma, Dermatol Online J, 5, 4 Dalton, 2002, Lichenoid tissue reaction in malignant melanoma: a potential diagnostic pitfall, Am J Clin Pathol, 117, 766, 10.1309/JDY7-M43Y-J3JU-DW57 Weedon, 2002 Spitz, 1951, Cutaneous tumors of childhood. Disparity between clinical behavior and histologic appearance, J Am Med Womens Assoc, 6, 209 Urso, 2006, Sentinel lymph node biopsy in patients with “atypical Spitz tumors.” A report on 12 cases, Hum Pathol, 37, 816, 10.1016/j.humpath.2006.02.001 Roaten, 2005, Survival in sentinel lymph node-positive pediatric melanoma, J Pediatr Surg, 40, 988, 10.1016/j.jpedsurg.2005.03.014 Gelbard, 2002, Management of Spitz nevi: a survey of dermatologists in the United States, J Am Acad Dermatol, 47, 224, 10.1067/mjd.2002.121031 Blessing, 1992, Histological regression in primary cutaneous melanoma: recognition, prevalence and significance, Histopathology, 20, 315, 10.1111/j.1365-2559.1992.tb00988.x High, 2005, Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria, J Am Acad Dermatol, 53, 89, 10.1016/j.jaad.2005.03.006 Flax, 1998, Nodular melanosis due to epithelial neoplasms: a finding not restricted to regressed melanomas, Am J Dermatopathol, 20, 118, 10.1097/00000372-199804000-00002 Clark, 1989, Model predicting survival in stage I melanoma based on tumor progression, J Natl Cancer Inst, 81, 1893, 10.1093/jnci/81.24.1893 Slingluff, 1988, Lethal “thin” malignant melanoma. Identifying patients at risk, Ann Surg, 208, 150, 10.1097/00000658-198808000-00004 Ronan, 1987, Thin malignant melanomas with regression and metastases, Arch Dermatol, 123, 1326, 10.1001/archderm.123.10.1326 Naruns, 1986, Recurrence of potential thin primary melanomas, Cancer, 57, 545, 10.1002/1097-0142(19860201)57:3<545::AID-CNCR2820570323>3.0.CO;2-K Sondergaard, 1985, Partial regression in thin primary cutaneous malignant melanomas clinical stage I, Virchows Arch A Pathol Anat Histopathol, 408, 241, 10.1007/BF00707986 Paladugu, 1983, Biologic behavior of thin malignant melanomas with regressive changes, Arch Surg, 118, 41, 10.1001/archsurg.1983.01390010031008 Gromet, 1978, The regressing thin malignant melanoma: a distinctive lesion with metastatic potential, Cancer, 42, 2282, 10.1002/1097-0142(197811)42:5<2282::AID-CNCR2820420528>3.0.CO;2-V Fontaine, 2003, Partial regression of primary cutaneous melanoma, Am J Dermatopathol, 25, 371, 10.1097/00000372-200310000-00002 Shaw, 1987, Thin malignant melanomas and recurrence potential, Arch Surg, 122, 1147, 10.1001/archsurg.1987.01400220057011 Cooper, 1985, Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance, Arch Dermatol, 121, 1127, 10.1001/archderm.121.9.1127 Kelly, 1985, Regression in malignant melanoma. A histologic feature without independent prognostic significance, Cancer, 56, 2287, 10.1002/1097-0142(19851101)56:9<2287::AID-CNCR2820560924>3.0.CO;2-Y Briggs, 1984, Experience of thin cutaneous melanomas (less than 0.76 mm and less than 0.85 mm thick) in a large plastic surgery unit: a 5 to 17 year follow-up, Br J Plast Surg, 37, 501, 10.1016/0007-1226(84)90139-5 Trau, 1983, Metastases of thin melanomas, Cancer, 51, 553, 10.1002/1097-0142(19830201)51:3<553::AID-CNCR2820510332>3.0.CO;2-T McGovern, 1983, Prognosis in patients with thin malignant melanoma: influence of regression, Histopathology, 7, 673, 10.1111/j.1365-2559.1983.tb02279.x McGovern, 1979, Prognostic significance of the histological features of malignant melanoma, Histopathology, 1, 385, 10.1111/j.1365-2559.1979.tb03020.x Slingluff, 1992, Thin malignant melanoma: risk factors and clinical management, Ann Plast Surg, 28, 89, 10.1097/00000637-199201000-00023 Nahabedian, 2003, Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?, Ann Plast Surg, 50, 601, 10.1097/01.SAP.0000069065.00486.1E Wong, 2006, Results of sentinel lymph node biopsy in patients with thin melanoma, Ann Surg Oncol, 13, 302, 10.1245/ASO.2006.02.021 Liszkay, 2005, Relationship between sentinel lymph node status and regression of primary malignant melanoma, Melanoma Res, 15, 509, 10.1097/00008390-200512000-00005 Carlson, 1995, Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases, Cancer, 75, 478, 10.1002/1097-0142(19950115)75:2<478::AID-CNCR2820750211>3.0.CO;2-O Reed RJ. Spindle-cell neoplasia. Presented at the annual meeting of the American Academy of Dermatology. New Orleans, LA, March 19–24, 1999. Jensen, 2004, Procollagen 1 expression in atypical fibroxanthoma and other tumors, J Cutan Pathol, 31, 57, 10.1046/j.0303-6987.2004.0145.x Tripp, 2002, Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology, J Am Acad Dermatol, 46, 674, 10.1067/mjd.2002.121029 Smoller, 1992, Dysplastic nevi can be diagnosed and graded reproducibly: a longitudinal study, J Am Acad Dermatol, 27, 399, 10.1016/0190-9622(92)70206-U Kossard, 2002, Atypical lentiginous junctional naevi of the elderly and melanoma, Australas J Dermatol, 43, 93, 10.1046/j.1440-0960.2002.t01-1-00568.x King, 2005, Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus, Mod Pathol, 18, 1397, 10.1038/modpathol.3800454 Davis, 2007, Histological evolution of lentiginous melanoma: a report of five new cases, J Cutan Pathol, 34, 296, 10.1111/j.1600-0560.2006.00604.x High, 2006, Is melanocytic nevus with focal atypical epithelioid components (clonal nevus) a superficial variant of deep penetrating nevus?, J Am Acad Dermatol, 55, 460, 10.1016/j.jaad.2006.04.054 Maize, 2003, Ducking stray “magic bullets”: a Melan-A alert, Am J Dermatopathol, 25, 162, 10.1097/00000372-200304000-00013 Demartini, 2005, Melan-A/MART-1 positive “pseudonests” in lichenoid inflammatory lesions: an uncommon phenomenon, Am J Dermatopathol, 27, 370, 10.1097/01.dad.0000157446.60118.d9